ACELIFT: a minimally invasive alternative to a facelift

Area of Science:

• Aesthetic Medicine
• Dermatology
• Cosmetic Surgery

Background:

• Cervicofacial aging involves skin laxity, deflation, submental fat, and rhytides.
• Facelift surgery is the traditional gold standard for treating these aging signs.
• Minimally invasive alternatives are sought to address aging concerns with less downtime.

Purpose of the Study:

• To evaluate the ACELIFT (Augmentation of Collagen and Elastin using Lasers, Injectable neurotoxins, Fillers, and Topicals) as a safe and effective alternative to facelift surgery.
• To assess patient and physician satisfaction with the ACELIFT procedure.
• To document the safety profile and side effects associated with the ACELIFT treatment.

Main Methods:

• A prospective study enrolled 10 women (ages 50-62) with signs of cervicofacial aging.
• The two-step ACELIFT involved laser lipolysis followed by a combination of neurotoxin, fillers, and fractional CO2 laser resurfacing.
• A topical regimen of sunscreen, antioxidants, retinoids, and peptides was applied for six months post-procedure.

Main Results:

• Significant clinical improvement was observed in all subjects nine months post-treatment.
• High physician and subject satisfaction scores were reported, with a high likelihood of recommendation.
• Side effects were mild and transient, with no serious adverse events like scarring or nerve injury.

Conclusions:

• ACELIFT is a safe, effective, and minimally invasive option for selected patients experiencing cervicofacial aging.
• The procedure offers a viable alternative to traditional facelift surgery with reduced downtime.
• High patient satisfaction underscores the cosmetic benefits and tolerability of the ACELIFT approach.